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Abstract 
DND1 is a RNA binding protein. Initially identified 
in the zebrafish, where knockdown of dnd in the 
early embryo resulted in loss of primordial germ 
cells (Weidinger et al., 2003). Mutations in Dnd1 in 
mice and rats, thought to result in expression of a 
truncated DND1 protein, are oncogenic and result in 
germ cell depletion as well as germ cell tumors 
(Youngren et al., 2005; Northrup et al., 2012). 
DND1 is required for the survival of primordial germ 
cells during early development. Primordial germ 
cells are the stem cells from which germ cell tumors 
arise (Stevens, 1967). Total deficiency of DND1 in 
mice results in early embryonic lethality (Zechel et 
al., 2013). In humans, mutations and deregulation of 
DND1 expression have been reported in testicular 
cancer as well as other types of cancers (Bhandari et 
al., 2012; Linger et al., 2008; Liu et al., 2010; 
Sijmons et al., 2010). One function of DND1 is as a 
translational regulator (Kedde et al., 2007). 
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Identity 
Other names: MGC34750; RBMS4 
HGNC (Hugo): DND1 
Location: 5q31.3, located between bases 
140,670,794-140,673,586 on the reverse strand of 
human Chr 5 (Ensembl). 
Local order: Flanking DND1 on the 5' end is 
WDR55 (WD repeat domain 55) located on the 
forward strand, followed by DND1 (on reverse 
strand) and at the 3'-end, HARS (histidyl-tRNA 
synthetase) (on the reverse strand). 
DNA/RNA 
Transcription 
Unlike human DND1, mouse Dnd1 encodes two 
alternate spliced transcripts that differ at the N-
terminus and which give rise to α and β-isoforms of 
DND1. DND1-α is expressed in early embryos and 
DND1-β in the germ cells of adult testis 
(Bhattacharya et al., 2007). 
Protein 
Description 
DND1 contains a RNA recognition motif (RRM) 
through which it interacts with mRNA (Northrup et 
al., 2012; Weidinger et al., 2003; Youngren et al., 
2005). 
It also has a double strand RNA binding domain 
(DSRM) at the C-terminus end, the function of 
which has not been evaluated. DND1 has sequence 
similarity with A1cf, which is a RNA binding 
subunit of the Apobec1 cytidine deaminase that edits 
specific sites in specific mRNAs (Youngren et al., 
2005). A conserved HRAAAMA motif is found in 
DND1 and in A1cf (Zechel et al., 2013) and the 
ATPase activity of zebrafish Dnd is ascribed to this 
motif (Liu and Collodi, 2010). 
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Human DND1 has 1 transcript (1605 bp) encoding a protein of 353 aa. Human DND1 has a RNA recognition motif (RRM), 
double strand RNA binding domain (DSRM), and the HRAAAMA motif (that is also found in mouse and rat DND1). 
 
Expression 
Expressed in embryonic and adult germ cells, the 
gonads and in testicular germ cell tumors 
(Bhattacharya et al., 2007; Northrup et al., 2012; 
Weidinger et al., 2003; Youngren et al., 2005). Also 
expressed in other cell types such as skin and 
pancreas (Basu et al., 2011; Bhandari et al., 2012). Is 
expressed in the early embryo of Xenopus 
(Bauermeister et al., 2015; Mei et al., 2013). 
Localisation 
ND1 localizes to the cytoplasm in perinuclear sites 
as well as in the nucleus of some cell types 
(Bhattacharya et al., 2008; Bhattacharya et al., 2007; 
Mickoleit et al., 2011; Slanchev et al., 2009). In the 
cytoplasm of male embryonic germ cells, DND1 co-
localizes with NANOS2 in P-bodies (Suzuki et al., 
2015). 
The Xenopus Dnd protein has a germplasm 
localization signal and nuclear localization signal. In 
the fertilized embryo, Dnd moves from the cortex to 
the perinuclear region with germplasm and enters the 
nucleus. It is speculated that Dnd carries RNA into 
the nucleus to trigger germline specification 
(Taguchi et al., 2014). 
Function 
DND1 is implicated in different aspects of 
translation regulation that impact embryonic and 
primordial germ cell development and cancer. The 
molecular function of DND1 has been delineated 
from studies in rodents, zebrafish and Xenopus. 
 (a)  DND1 binds to the 3'-UTR (untranslated region) 
of mRNAs to displace miRNA interaction with 
specific mRNAs (Kedde et al., 2007; Liu et al., 
2010). For example, DND1 blocks access of specific 
miRNAs to their 3' target in CDKN1B (P27) and 
LATS2 mRNA. Human and mouse DND1 interacts 
with mRNAs that encode pluripotency factors 
(POU5F1 (OCT4), SOX2 , NANOG, LIN28), 
regulators of cell cycle (LATS2, TP53, p21 and p27) 
and apoptotic factors (BCL2L1 (BCLX) andBAX) 
(Cook et al., 2011; Zhu et al., 2011). 
Zebrafish DND1 blocks miR-430 from huB, Nanos 
and TDRD7 3'-UTR and also regulates translation of 
geminin mRNA through binding to its 3? -UTR 
(Chen et al., 2010; Kedde et al., 2007; Mickoleit et 
al., 2011). 
 (b)  DND1 interacts with apolipoprotein B editing 
complex 3 (APOBEC3) (Bhattacharya et al., 2008). 
Human APOBEC3G inhibits DND1 function. 
APOBEC3G blocks DND1 function to restore the 
translational inhibitory effect of miRNAs on the 3'-
UTR of P27, LATS2 and GJA1 (CX43) (Ali et al., 
2013). 
Mouse c-JUN interacts with DND1 and co-localizes 
to the nuclei. DND1 and c-JUN caused increased 
transcriptional activity of activator protein 1 (Zhang 
et al., 2015). 
 (c)  Mouse DND1 directly interacts with NANOS2 
to load specific mRNAs into the CCR4-NOT 
(CNOT) deadenylase complex (Suzuki et al., 2015). 
This results in translational suppression of specific 
RNAs that are required during germ cell 
development and thus conditional deletion of DND1 
disrupts male germ cell differentiation. 
 (d)  Zebrafish DND1 protein possesses Mg(2+)-
dependent ATPase activity that is required for 
primordial germ cell viability and formation. The 
ATPase region is mapped to the C terminus of DND1 
(Liu and Collodi, 2010). 
 (e)  DND1 transports mRNA transcripts from germ 
cell nuclei to germ cell granules (Slanchev et al., 
2009). 
 (f)  Deletion of DND1 in mice indicates it is 
essential for embryonic viability (Zechel et al., 
2013). Repression or ablation of Dnd In Xenopus 
and zebrafish embryos results in loss of primordial 
germ cells and their failure to migrate into the 
developing gonads (Horvay et al., 2006; Weidinger 
et al., 2003). 
(g) In the early embryo of Xenopus, Dnd is required 
to regionally anchor key regulators of the vegetal 
cortical microtubule assembly for axis specification. 
Dnd binds to 3'-UTR of trim36, an E3 ubiquitin 
ligase, which is essential for microtubule assembly. 
The microtubules translocate dorsal determinants. 
Lack of Dnd causes ventralization of frog embryos 
(Mei et al., 2013). 
In turn, Xenopus Dnd mRNA is localized vegetally 
to the RNP complex by Celf, a component of the 
vegetal localization RNP complex (Bauermeister et 
al., 2015). Celf interacts with the late element (LE) 
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of Dnd RNA. LE of Dnd mRNA also interacts with 
Elavl1 and Elav2 (Arthur et al., 2009). 
Implicated in 
Germ cell tumors including 
Testicular Germ Cell Tumors (TGCTs 
or testicular cancer) and Ovarian 
germ cell tumors (OGCTs) 
The 5q31.3 region encompassing DND1 is 
frequently deleted in male TGCTs (al-Jehani et al., 
1995; Faulkner et al., 2000; Peng et al., 1999). Two 
studies detected DND1 mutations upon sequencing 
the exons of DND1 in patients with TGCTs (Linger 
et al., 2008 ; Sijmons et al., 2010) although mutations 
in DND1 appear to be rare in human TGCTs.  
In one study, DNA from 263 familial and sporadic 
TGCT patients were sequenced. A possible 
pathogenic missense mutation in exon 3 (c.A301C, 
p.Glu86Ala) was identified in one patient. This 
mutation resides within the functional, evolutionary 
conserved RNA recognition motif (Linger et al., 
2008).  
In another study, sequencing exons 1 to 4 of DND1 
from peripheral blood lymphocytes in 272 men, with 
both sporadic and familial TGCT, detected one non 
familial mutation (c.C657G, p.Asp219Glu) in exon 
4. The wild-type DND1 was not lost in the patient 
(Sijmons et al., 2010).  
Analysis of the human DND promoter revealed 15 
CpG sites. However, no significant differences in 
CpG methylation levels have been observed in DNA 
from blood of patients with TGCT cases compared 
to controls (Mirabello et al., 2012). 
Oncogenesis 
The function DND1 in TGCT oncogenesis has been 
gleaned from studies in rodent models.  
The Ter mutation is a single base substitution in exon 
3 of Dnd1 that transforms an arginine residue to a 
premature stop codon (p.Arg178X) (Youngren et al., 
2005). In the 129 mouse, the Ter mutation (in 
DND1) has been characterized as a modifier gene for 
amplifying the incidence of spontaneous TGCTs 
(Asada et al., 1994; Noguchi and Stevens, 1982). 
The 129-Ter mouse is a model for prepubertal type I 
testicular germ cell tumors (Oosterhuis and 
Looijenga, 2005). Neoplastic transformation of germ 
cells and tumorigenesis takes place during 
embryogenesis (Noguchi and Noguchi, 1985; 
Stevens, 1967). The germ cells in Ter male mice fail 
to enter mitotic arrest in G0 (Cook et al., 2011)  
A complete loss-of-function of DND1 leads to early 
embryonic lethality. However, the loss-of-function 
Dnd1 allele does not cause TGCT (Zechel et al., 
2013).  
In Ter-WKY/Ztm rats, a point mutation in exon 4 of 
rat Dnd1 introduces a premature stop codon that 
likely results in expression of a C-terminus truncated 
DND1 protein. This results in congenital ovarian 
germ cell tumors (OGCTs) in females and TGCTs in 
males (Northrup et al., 2012). Thus DND1/Ter acts 
as a tumor suppressor in the rat.  
Germ cells derived from rat Ter embryos are more 
easily transformed into pluripotent cells in culture 
compared to their wild type counterparts (Northrup 
et al., 2011). 
Skin tumorigenesis 
RAS transformed human HaCaT cells show reduced 
expression of DND1, loss of DND1 mRNA and 
protein (Bhandari et al., 2012). In this cell type, 
DND1 blocks miR-21 from the 3'-UTR of the 
mRNA of the DNA repair gene MSH2. Thus, lower 
DND1 levels in RAS transformed HaCaT cells 
results in decreased MSH2 levels in the cell. 
Human tongue squamous cell 
carcinoma (TSCC) 
Human tongue squamous cell carcinoma (TSCC) 
cells and tumors up-regulate miR-24. In turn, miR-
24 interacts with the 3'-UTR of DND1 mRNA to 
reduce expression of DND1. Thus miR-24-mediated 
decrease in DND1 expression leads to decreased 
cyclin-dependent kinase inhibitor 1B (CDKN1B/ 
P27) expression and enhanced proliferation and 
reduced apoptosis in TSCC cells (Liu et al., 2010). 
Colon tumorigenesis 
The truncated DND1 mutant (Ter) significantly 
increases polyp number and burden in the Apc+/Min 
model of intestinal polyposis (Zechel et al., 2013). 
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